The human epidermal growth factor receptor 2 (HER2) is amplified or overexpressed in ∼ 20% of human breast carcinomas and is associated with a more aggressive phenotype and worse prognosis [1]. The gene discussed is ERBB2; the disease is breast carcinoma.